X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4) 4
adult (3) 3
aged (3) 3
female (3) 3
index medicus (3) 3
male (3) 3
middle aged (3) 3
oncology (3) 3
aged, 80 and over (2) 2
analysis (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
biomarkers (2) 2
cancer (2) 2
carcinoma (2) 2
cells (2) 2
double-blind method (2) 2
drug therapy (2) 2
expression (2) 2
medicine, general & internal (2) 2
neoplasm staging (2) 2
original paper (2) 2
patients (2) 2
prognosis (2) 2
survival (2) 2
survival rate (2) 2
treatment outcome (2) 2
tumors (2) 2
13-cis-retinoic acid (1) 1
abridged index medicus (1) 1
acceptance of illness (1) 1
activation (1) 1
acute myeloblastic-leukemia (1) 1
acute myelogenous leukaemia (1) 1
acute myeloid-leukemia (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adhesive strength (1) 1
all-trans retinoic acid (1) 1
all-trans retinoid acid (1) 1
all‐trans retinoic acid (1) 1
amg 102 (1) 1
amg 386 (1) 1
aml blasts (1) 1
amplification (1) 1
animals (1) 1
annual reports (1) 1
anthracyclines (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
antigens, cd - metabolism (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
apoptosis (1) 1
article (1) 1
bacterial toxins - metabolism (1) 1
bcl- 2 (1) 1
bcl-2 (1) 1
bcl‐2 (1) 1
benzenesulfonates - therapeutic use (1) 1
bevacizumab (1) 1
bioactive lipids (1) 1
biomarkers, tumor - metabolism (1) 1
blood cells (1) 1
bone marrow - pathology (1) 1
bone-marrow (1) 1
breast cancer (1) 1
breast-cancer (1) 1
c-met (1) 1
cancer therapies (1) 1
capecitabine (1) 1
carcinoma, renal cell - drug therapy (1) 1
carcinoma, renal cell - mortality (1) 1
carcinoma, renal cell - secondary (1) 1
cd34 antigen (1) 1
cd59 antigen (1) 1
cell adhesion - drug effects (1) 1
cell biology (1) 1
cell surface (1) 1
cellular biology (1) 1
chemokine cxcl12 - pharmacology (1) 1
chemotaxis - drug effects (1) 1
chemotherapy (1) 1
circulating level (1) 1
cisplatin - adverse effects (1) 1
cisplatin - therapeutic use (1) 1
clear cell renal cell carcinoma (1) 1
clinical research (1) 1
colorectal cancer (1) 1
complement (1) 1
confidence intervals (1) 1
coping with pain (1) 1
countries (1) 1
cxcr4 (1) 1
cxcr4 protein (1) 1
cyclooxygenase-2 (1) 1
cytarabine - administration & dosage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ARCHIVES OF MEDICAL SCIENCE, ISSN 1734-1922, 10/2019, Volume 15, Issue 6, pp. 1433 - 1442
Introduction: Triple negative breast cancer (TNBC) is characterized by a worse prognosis than other breast cancer subtypes. TNBC is defined by lack of... 
SURVIVAL | erythropoietin receptor | MEDICINE, GENERAL & INTERNAL | SUBTYPES | GROWTH | immunohistochemical examination | ERYTHROPOIETIN RECEPTOR EXPRESSION | triple negative breast cancer | CARCINOMA | erythropoietin | FEATURES | Breast cancer | Clinical Research
Journal Article
Archives of Medical Science, ISSN 1734-1922, 2018, Volume 14, Issue 6, pp. 1439 - 1449
Introduction: In developed countries, malignant tumours are the second most common cause of death after cardiovascular diseases. The estimates made by... 
Malignant tumour | Health policy programme | Local government unit | BREAST-CANCER | SURVIVAL | MEDICINE, GENERAL & INTERNAL | COUNTRIES | health policy programme | local government unit | END | malignant tumour | TRENDS | Annual reports | Local government | Cancer | Tumors | Public Health
Journal Article
Przeglad Gastroenterologiczny, ISSN 1895-5770, 2016, Volume 11, Issue 2, pp. 96 - 103
Every year more than 15,000 newly diagnosed cases of colorectal carcinoma are recorded in Poland. The objective of the study was an assessment of coping... 
Coping With Pain | Acceptance Of Illness | Patients | Analysis | Colorectal cancer | Pain management | Original Paper | coping with pain | acceptance of illness
Journal Article
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 09/2015, Volume 19, Issue 9, pp. 2193 - 2201
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2014, Volume 18, Issue 6, pp. 409 - 415
Aim of the study: Cyclooxygenase-2 (COX-2) expression has been observed in a substantial percentage of classical adenomas of the large bowel. The aim of the... 
Hyperplastic polyp | Cyclooxygenase-2 | Serrated neoplasia | Sessile serrated polyp | Traditional serrated adenoma | traditional serrated adenoma | serrated neoplasia | ONCOLOGY | hyperplastic polyp | sessile serrated polyp | cyclooxygenase-2 | Original Paper
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 1007 - 1018
Summary Background Dysregulation of the hepatocyte growth factor (HGF)/MET pathway promotes tumour growth and metastasis. Rilotumumab is a fully human,... 
Hematology, Oncology and Palliative Medicine | AMPLIFICATION | PHARMACOKINETICS | ONCOLOGY | HEPATOCYTE GROWTH-FACTOR | C-MET | MONOCLONAL-ANTIBODY | CIRCULATING LEVEL | AMG 102 | CANCER | EXPRESSION | CARCINOMA | Confidence Intervals | Adenocarcinoma - pathology | Esophagogastric Junction - drug effects | Prognosis | Capecitabine | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Stomach Neoplasms - pathology | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Fluorouracil - adverse effects | Neoplasm Invasiveness - pathology | Adult | Deoxycytidine - adverse effects | Female | Double-Blind Method | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Proportional Hazards Models | Esophagogastric Junction - pathology | Survival Rate | Treatment Outcome | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Epirubicin - therapeutic use | Aged | Neoplasm Staging | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Epirubicin - adverse effects | Monoclonal antibodies | Anthracyclines | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 12/2012, Volume 118, Issue 24, pp. 6152 - 6161
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 02/2004, Volume 8, Issue 2, p. 107
  Irreversible cardiac toxicity often leads to death or permanent disability. Chemotherapy can cause heart damage. Anthracyclines, which belong to the most... 
Journal Article
Wspólczesna Onkologia, ISSN 1428-2526, 02/2004, Volume 8, Issue 2, p. 70
  In spite of so many analgesic drugs available today, and the relatively simple and effective guidelines to treat cancer pain published and recommended by the... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.